State Street’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$46.6M Sell
1,950,603
-28,758
-1% -$687K ﹤0.01% 1713
2025
Q1
$49.2M Buy
1,979,361
+13,893
+0.7% +$345K ﹤0.01% 1644
2024
Q4
$37M Sell
1,965,468
-48,544
-2% -$915K ﹤0.01% 1866
2024
Q3
$30.3M Buy
2,014,012
+110,162
+6% +$1.66M ﹤0.01% 1971
2024
Q2
$54.5M Buy
1,903,850
+238
+0% +$6.81K ﹤0.01% 1631
2024
Q1
$55.6M Sell
1,903,612
-32,546
-2% -$951K ﹤0.01% 1669
2023
Q4
$65.3M Buy
1,936,158
+150,919
+8% +$5.09M ﹤0.01% 1554
2023
Q3
$54.8M Buy
1,785,239
+67,093
+4% +$2.06M ﹤0.01% 1568
2023
Q2
$68.8M Buy
1,718,146
+35,813
+2% +$1.44M ﹤0.01% 1467
2023
Q1
$68.7M Buy
1,682,333
+66,767
+4% +$2.72M ﹤0.01% 1434
2022
Q4
$62.4M Sell
1,615,566
-84,062
-5% -$3.25M ﹤0.01% 1479
2022
Q3
$90.4M Buy
1,699,628
+45,155
+3% +$2.4M 0.01% 1170
2022
Q2
$96.5M Buy
1,654,473
+48,715
+3% +$2.84M 0.01% 1173
2022
Q1
$123M Buy
1,605,758
+75,757
+5% +$5.78M 0.01% 1151
2021
Q4
$92.1M Buy
1,530,001
+67,824
+5% +$4.08M ﹤0.01% 1362
2021
Q3
$81.9M Sell
1,462,177
-14,790
-1% -$828K ﹤0.01% 1432
2021
Q2
$89.6M Buy
1,476,967
+45,127
+3% +$2.74M ﹤0.01% 1385
2021
Q1
$100M Buy
1,431,840
+8,186
+0.6% +$574K 0.01% 1229
2020
Q4
$85.2M Buy
1,423,654
+10,744
+0.8% +$643K 0.01% 1267
2020
Q3
$84.9M Sell
1,412,910
-77,274
-5% -$4.65M 0.01% 1079
2020
Q2
$78.2M Buy
1,490,184
+86,525
+6% +$4.54M 0.01% 1135
2020
Q1
$47.1M Buy
1,403,659
+74,009
+6% +$2.48M ﹤0.01% 1295
2019
Q4
$60.2M Buy
1,329,650
+2,646
+0.2% +$120K ﹤0.01% 1387
2019
Q3
$50.5M Buy
1,327,004
+384,794
+41% +$14.6M ﹤0.01% 1428
2019
Q2
$41M Sell
942,210
-15,970
-2% -$695K ﹤0.01% 1610
2019
Q1
$36.5M Buy
958,180
+27,005
+3% +$1.03M ﹤0.01% 1639
2018
Q4
$40.1M Sell
931,175
-56,221
-6% -$2.42M ﹤0.01% 1496
2018
Q3
$48.5M Sell
987,396
-32,049
-3% -$1.58M ﹤0.01% 1554
2018
Q2
$32.7M Sell
1,019,445
-135,667
-12% -$4.35M ﹤0.01% 1788
2018
Q1
$36M Buy
1,155,112
+168,527
+17% +$5.25M ﹤0.01% 1643
2017
Q4
$45M Sell
986,585
-58,210
-6% -$2.66M ﹤0.01% 1490
2017
Q3
$39.2M Sell
1,044,795
-73,288
-7% -$2.75M ﹤0.01% 1537
2017
Q2
$53.3M Buy
1,118,083
+10,727
+1% +$512K ﹤0.01% 1314
2017
Q1
$50.5M Buy
1,107,356
+28,663
+3% +$1.31M ﹤0.01% 1321
2016
Q4
$34.8M Sell
1,078,693
-19,491
-2% -$629K ﹤0.01% 1502
2016
Q3
$37.6M Sell
1,098,184
-99,728
-8% -$3.41M ﹤0.01% 1372
2016
Q2
$40.4M Buy
1,197,912
+88,301
+8% +$2.98M ﹤0.01% 1291
2016
Q1
$58.8M Buy
1,109,611
+47,096
+4% +$2.5M 0.01% 1101
2015
Q4
$81.6M Sell
1,062,515
-26,081
-2% -$2M 0.01% 912
2015
Q3
$44.7M Sell
1,088,596
-11,410
-1% -$469K 0.01% 1236
2015
Q2
$77.8M Buy
1,100,006
+7,552
+0.7% +$534K 0.01% 998
2015
Q1
$97.1M Buy
1,092,454
+47,773
+5% +$4.24M 0.01% 892
2014
Q4
$92.6M Buy
1,044,681
+38,016
+4% +$3.37M 0.01% 893
2014
Q3
$97.6M Buy
1,006,665
+60,277
+6% +$5.84M 0.01% 838
2014
Q2
$86.9M Buy
946,388
+20,054
+2% +$1.84M 0.01% 927
2014
Q1
$64.8M Sell
926,334
-43,914
-5% -$3.07M 0.01% 1058
2013
Q4
$55.8M Buy
970,248
+194,044
+25% +$11.2M 0.01% 1138
2013
Q3
$37.3M Sell
776,204
-93,637
-11% -$4.5M ﹤0.01% 1318
2013
Q2
$25.2M Buy
+869,841
New +$25.2M ﹤0.01% 1491